A discussion surrounding highlights and updates from the 2023 World Stroke Congress.
EP. 1: DOAC Usage and Rapid Access to Reversal Agents
Stuart J Connolly, MD, FRCPC, discusses updated strategies for managing intracerebral hemorrhage, emphasizing the significance of timely diagnosis to improve hemostatic efficacy.
EP. 2: ANNEXA-I Study Overview
A medical expert discusses the findings of a randomized trial investigating the use of andexanet alfa versus usual care in patients with acute intracerebral hemorrhage (ICH) and recent direct oral anticoagulant (DOAC) use.
2 Clarke Drive Cranbury, NJ 08512